CANNASSURE THERAPEUTICS LTD

Inactief instrument

Andere talen Cannassure Therapeutics Ltd TEL AVIV STOCK EXCHANGE

Aandelen

CSURE

IL0001110134

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Cannassure Therapeutics Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	27/03
Cannassure Therapeutics Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	31-08-23
Cannassure Therapeutics Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	26-03-23
Cannassure Was Granted A Patent for an Oral Delivery Method of Cannabis and Cannabinoids Compositions by the Israel Patents Authority	09-08-21
DanCann Pharma A/S : publishes Year-end report for 2020	26-02-21
Cannassure Therapeutics : DanCann Pharma's strategic partner, Cannassure Therapeutics Ltd., enter exclusive licensing agreement regarding topical medical cannabis products based on Lipidor's AKVANO® technology	18-01-21
Lipidor : and Cannassure enter exclusive licensing agreement regarding topical medical cannabis products based on Lipidor's AKVANO technology	18-01-21
DanCann Pharma A/S : enter exclusive agreement with Cannassure Therapeutics to be multinational distributor for Scandinavia (Denmark, Norway, Sweden, and Finland)	15-12-20
Lipidor : publishes interim report for Q3 2020	19-11-20
Lipidor : announces positive outcome of feasibility study for development of topical medical cannabis products based on the company's AKVANO® technology	30-09-20
Cannassure Therapeutics : Ltd and Lipidor AB Enter a Feasibility Study and Licence Option Agreement for Development and Sales of Topical Medical Cannabis Products Based on AKVANO Technology	11-12-19
Lipidor (Nasdaq First North: LIPI) and Cannassure (TASE:CSURE) enter a feasibility study and licence option agreement for development and sales of topical medical cannabis products	10-12-19

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Krijg net zoals de experts toegang tot de transcripties en ontdek de beste kansen, nog voor de anderen.

Krijg nu toegang!

fermer